Then what’s the point of this article? Machine learning has been a critical aspect of drug discovery for a decade+ now. Anthropic is built on a cornerstone of transformer models. Presumably, they are wanting to implement a transformer based approach to drug discovery otherwise this is absolutely nothing new and that’s a TERRIBLE idea.
The point of the article is that they want to develop their own drugs. Not just hand over the model to drug companies for them to use and discover drugs.
The method is not new. But it’s new that Antrophic will have a drug division.
Well, AI for drugs is not a bad idea. Only because they can go through possible strings very fast, and then come up with some solutions to try.
AI is not in charge of testing, because how could it.
But drugs developed by AI, SHOULD be royalty free. But we all know it wont.
LLMs are not the type of AI to use for examining molecular chains.
Does it say they’re going to use an llm?
Then what’s the point of this article? Machine learning has been a critical aspect of drug discovery for a decade+ now. Anthropic is built on a cornerstone of transformer models. Presumably, they are wanting to implement a transformer based approach to drug discovery otherwise this is absolutely nothing new and that’s a TERRIBLE idea.
The point of the article is that they want to develop their own drugs. Not just hand over the model to drug companies for them to use and discover drugs.
The method is not new. But it’s new that Antrophic will have a drug division.